The Oncology Institute, Inc. TOI Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s interest expense?
- The Oncology Institute, Inc. (TOI) reported interest expense of $1.93M in Q1 2026.
- How has The Oncology Institute, Inc.'s interest expense changed year-over-year?
- The Oncology Institute, Inc.'s interest expense decreased by 65.3% year-over-year, from $5.57M to $1.93M.
- What is the long-term trend for The Oncology Institute, Inc.'s interest expense?
- Over 2 years (2023 to 2025), The Oncology Institute, Inc.'s interest expense has grown at a 29.0% compound annual growth rate (CAGR), from $6.78M to $11.28M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.